[1]杨 华a,李致文b,曹明善a,等.急性脑梗死患者血清miR-130a 水平表达与溶栓后再出血转化风险的预测模型及验证[J].现代检验医学杂志,2022,37(06):28-33+75.[doi:10.3969/j.issn.1671-7414.2022.06.006]
　YANG Huaa,LI Zhi-wenb,CAO Ming-shana,et al.Prediction Model and Validation of Serum miR-130a Expression in Patients with Acute Cerebral Infarction and the Risk of Hemorrhagic Transformation after Thrombolysis[J].Journal of Modern Laboratory Medicine,2022,37(06):28-33+75.[doi:10.3969/j.issn.1671-7414.2022.06.006]
点击复制

急性脑梗死患者血清miR-130a 水平表达与溶栓后再出血转化风险的预测模型及验证()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第37卷
期数:
2022年06期
页码:
28-33+75
栏目:
论著
出版日期:
2022-11-15

文章信息/Info

Title:
Prediction Model and Validation of Serum miR-130a Expression in Patients with Acute Cerebral Infarction and the Risk of Hemorrhagic Transformation after Thrombolysis
文章编号:
1671-7414(2022)06-028-07
作者:
杨 华a; 李致文b; 曹明善a; 殷海清b; 黄红革a
(邢台市第三医院 a. 检验科；b. 神经内科，河北邢台 054000)
Author(s):
YANG Huaa;  LI Zhi-wenb;  CAO Ming-shana;  YIN Hai-qingb;  HUANG Hong-gea
(a. Department of Laboratory Medicine; b. Department of Neurology, the Third Hospital of Xingtai City, Hebei Xingtai 054000, China)
关键词:
急性脑梗死; 出血转化; 微小核糖核酸-130a; 溶栓; 列线图模型
分类号:
R743.33；R392.11
DOI:
10.3969/j.issn.1671-7414.2022.06.006
文献标志码:
A
摘要:
目的 研究微小核糖核酸(micro RNA, miR)-130a 与急性脑梗死(acute cerebral infarction，ACI) 患者溶栓后再出血转化的关系，并分析再出血转化的危险因素，建立列线图预测模型。方法 纳入2018 年8 月～ 2020 年8 月于邢台市第三医院诊治的175 例急性脑梗死患者作为建模组，根据出血转化情况分为发生组、未发生组，另纳入同期于该院诊治的100 例急性脑梗死患者作为验证组。比较发生组、未发生组的miR-130a 表达情况，采用ROC 曲线分析miR-130a对于出血转化的预测价值。应用单因素、多因素Logistic 回归模型分析出血转化的影响因素。应用R 软件建立预测急性脑梗死患者溶栓后出血转化的列线图模型并进行验证，采用ROC 曲线分析该模型预测建模组、验证组患者发生出血转化的效能。结果 建模组中再出血转化组(发生组)45 例，未发生组130 例，出血转化率为25.71%。单因素、多因素Logistic 回归分析显示心房颤动(OR=1.684，95%CI：1.124 ～ 2.521)、基线NIHSS 评分(OR=2.627，95%CI：1.169 ～ 5.903)、溶栓药物剂量(OR=0.535，95%CI：0.306 ～ 0.938 )、溶栓前血糖(OR=12.305，95%CI：1.250 ～ 4.248 )、CT 早期梗死面积(OR=1.747，95%CI：1.144 ～ 2.668)和miR-130a(OR=2.106，95%CI：1.123 ～ 3.952)均是急性脑梗死患者溶栓后再出血转化的影响因素(均P ＜ 0.05)。ROC 曲线分析显示，血清miR-130a 预测再出血转化的最佳截断值为1.08，曲线下面积为0.803(95%CI：0.730 ～ 0.876)。列线图模型预测建模组与验证组的C-index 分别为0.844 和0.816。建模组的AUC为0.823(95%CI：0.753 ～ 0.894)，敏感度和特异度分别为88.89%，76.92%，验证组的AUC为0.797 (95%CI：0.722 ～ 0.872)，敏感度和特异度分别为81.82%，74.36%。结论 心房颤动、基线NIHSS 评分、溶栓药物剂量、溶栓前血糖、CT 早期梗死面积和miR-130a 均是急性脑梗死患者溶栓后再出血转化的影响因素，以这6 项指标建立的列线图模型具有良好的再出血转化预测效能。
Abstract:
Objective To study the relationship between miR-130a and rebleeding transformation after thrombolysis in patients with acute cerebral infarction(ACI), analyze the risk factors of rebleeding transformation, and establish a nomogram prediction model. Methods 175 patients with ACI who were diagnosed and treated in the Third Hospital of Xiangtai City from August 2018 to August 2020 were included as the modeling group. According to the bleeding transformation, they were divided into an occurrence group and a non-occurrence group. In addition, 100 patients with ACI diagnosed and treated in the Third Hospital of Xingtai City during the same period were included as the verification group. The expression of miR-130a in the occurrence group and the non-occurrence group was compared, and the ROC curve was used to analyze the predictive value of miR-130a for hemorrhage transformation. Single-factor and multi-factor Logistic regression model was used to analyze the influencing factors of hemorrhage transformation. The R software was used to establish and verify the nomogram model for predicting hemorrhage transformation after thrombolysis in patients with acute cerebral infarction. The ROC curve was used to analyze the effectiveness of the model to predict hemorrhage transformation in themodeling group and the verification group. Results In the modeling group, there were 45 cases in the rebleeding conversion group (occurrence group) and 130 cases in the non-occurring group. The bleeding conversion rate was 25.71%. Univariate and multivariate Logistic regression analysis showed atrial fibrillation (OR=1.684, 95%CI: 1.124 ～ 2.521), baseline NIHSS score (OR=2.627，95%CI：1.169 ～ 5.903), thrombolytic drug dose (OR=0.535，95%CI：0.306 ～ 0.938), prethrombolysis blood glucose (OR=12.305，95%CI: 1.250 ～ 4.248), CT early infarct area (OR=1.747，95%CI: 1.144 ～ 2.668) and miR-130a (OR=2.106，95%CI: 1.123 ～ 3.952) were the influencing factors of rebleeding transformation after thrombolysis in patients with acute cerebral infarction (P ＜ 0.05). ROC curve analysis showed that the best cut-off value of serum miR-130a for predicting rebleeding transformation was 1.08, and the area under the curve was 0.803 (95%CI: 0.730 ～ 0.876). The C-index of the nomogram model predictive modeling group and verification group were 0.844 and 0.816, respectively. The AUC of the modeling group was 0.823 (95%CI: 0.753 ～ 0.894), the sensitivity and specificity were 88.89% and 76.92%, respectively. The AUC of the verification group was 0.797 (95%CI: 0.722 ～ 0.872), the sensitivity and specificity were 81.82% and 74.36% respectively. Conclusion Atrial fibrillation, baseline NIHSS score, thrombolytic drug dosage, blood glucose before thrombolysis, CT early infarct size, and miR-130a were all influencing factors for the transformation of rebleeding after thrombolysis in patients with acute cerebral infarction. The nomogram model established by the above 6 indicators has a good performance in predicting the conversion of rebleeding.

参考文献/References:

[1] SUN Z, XU Q, GAO G, et al. Clinical observation in edaravone treatment for acute cerebral infarction[J]. Nigerian Journal of Clinical Practice, 2019, 22(10): 1324-1327.
[2] 高想杰 , 任丽华 .rt-PA与尿激酶静脉溶栓治疗不同时间窗急性脑梗死的疗效分析 [J].中风与神经疾病杂志 , 2019, 36(6)：520-522. GAO Xiangjie, REN Lihua. The effect of rt-PA and urokinase intravenous thrombolytic therapy for actue cerebral infarction within different time windows [J]. Journal of Apoplexy and Nervous Diseases, 2019, 36(6): 520-522.
[3] WU Tao, LI Peiling, SUN Deke. Assessing the clinical e?cacy of recombinant tissue plasminogen activator on acute cerebral infarction[J]. Journal of Nanoscience and Nanotechnology, 2020, 20(12): 7781-7786.
[4] 王伟 .急性脑梗死静脉溶栓治疗后所致脑出血的研究进展 [J].中国中西医结合急救杂志 , 2019, 26(5): 638-640. WANG Wei. Research progress of cerebral hemorrhage after intravenous thrombolytic therapy for acute cerebal infartion [J]. Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care, 2019, 26(5): 638-640.
[5] 陈南耀 , 余丹 .联合检测血清 miR-124与 miR-182的表达水平对急性脑梗死诊断与预后评估的价值 [J].中国动脉硬化杂志 , 2019, 27(6)：502-506. CHEN Nanyao, YU Dan. The value of combined detection of the expression levels of serum microRNA-124 and microRNA-182 in diagnosis and prognosis of acute cerebral infarction [J]. Chinese Journal of Arteriosclerosis, 2019, 27(6): 502-506 .
[6] WANG Mengdie, WANG Yong, XIA Yuanpeng, et al. High serum miR-130a levels are associated with severe perihematomal edema and predict adverse outcome in acute ICH[J]. Molecular Neurobiology, 2016, 53(2): 1310-1321.
[7] 中华医学会神经病学分会 , 中华医学会神经病学分会脑血管病学组 .中国急性缺血性脑卒中诊治指南 2018[J].中华神经科杂志 , 2018, 51(9)：666-682. Chinese Society of Neurology, Chinese Stroke Society. Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2018 [J]. Chinese Journal of Neurology, 2018, 51(9):666- 682.
[8] 中华医学会神经病学分会 , 中华医学会神经病学分会脑血管病学组 .中国急性脑梗死后出血转化诊治共识 2019[J].中华神经科杂志 , 2019, 52(4)：252-265. Chinese Society of Neurology, Chinese Stroke Society. Consensus on diagnosis and treatment of hemorrhagic transformation after acute ischemic stroke in China 2019 [J]. Chinese Journal of Neurology, 2019, 52(4): 252- 265.
[9] 庞永博 , 胡倩 , 伊恋 , 等 .脑梗死后出血转化的病因研究进展 [J].国际神经病学神经外科学杂志 , 2018, 45(6)：641-644. PANG Yongbo, HU Qian, YI Lian, et al. Research progress in the etiology of hemorrhagic transformation after cerebral infarction[J]. Journal of International Neurology and Neurosurgery, 2018, 45(6): 641-644.
[10] 盛良驹 , 赵天 , 高传美 , 等 .头颅 CT灌注成像对急性脑梗死后出血转化预测的价值 [J].临床放射学杂志 , 2020, 39(2)：256-260. SHENG Liangju, ZHAO Tian, GAO Chuanmei, et al. Value of CT perfusion imaging in predicting hemorrhage transformation after acute cerebral infarction [J]. Journal of Clinical Radiology, 2020, 355(2): 256-260.
[11] 刘鸣 .急性脑梗死后出血转化诊断与处理 [J].中华神经科杂志 , 2020, 53(3)：213-216. LIU Ming. Diagnosis and treatment of hemorrhagic transformation after acute ischemic stroke [J]. Chinese Journal of Neurology, 2020, 53(3):213-216.
[12] 杨赓 .个体化预测急性心力衰竭患者并发急性肾损伤风险列线图模型的建立及验证 [J].中国实用内科杂志 , 2018, 38(7)：633-637. YANG Geng. Development and validation of a predictive nomogram of assessing the acute Kidney injury in patients with acute heart failure [J]. Chinese Journal of Practical Internal Medicine,2018,38(7):633-637.
[13] EMBERSON J, LEES K R, LYDEN P, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials[J]. Lancet, 2014, 384(9958): 1929-1935.
[14] ZHANG Zhaoting, QIAN Mingyue, GE Zhonglin, et al. Effects of blood glucose and glycosylated hemoglobin levels on intravenous thrombolysis in patients with acute cerebral infarction and type 2 diabetes mellitus[J]. Pakistan Journal of Medical Sciences, 2019, 35(3): 862-867.
[15] 陈菲 , 王碧 .血清 PDGF 及 SDF-1 水平与急性脑梗死患者脑侧支循环建立的相关性研究 [J].现代检验医学杂志 , 2020, 35(1): 82-85. CHEN Fei, WANG Bi. Study on the correlation between levels of MMP-9 and SDF-1 in serum and the establishment of cerebral collateral circulation in patients with acute cerebral infarction [J]. Journal of Modern Laboratory Medicine,2020,35(1):82-85.
[16] NIESEN W D, SCHLAEGER A, REINHARD M, et al. Transcranial sonography to differentiate primary intracerebral hemorrhage from cerebral infarction with hemorrhagic transformation[J]. Journal of Neuroimaging, 2018, 28(4): 370-373.
[17] WANG Yong, WANG Mengdie, XIA Yuanpeng, et al. MicroRNA-130a regulates cerebral ischemia-induced blood-brain barrier permeability by targeting Homeobox A5[J]. FASEB Journal, 2018, 32(2): 935-944.

相似文献/References:

[1]何凤娥,刘依霜,段春艳.ACI患者TEG各项参数与PAgT和D-二聚体之间的相关性[J].现代检验医学杂志,2017,32(01):134.[doi:10.3969/j.issn.1671-7414.2017.01.037]
　HE Feng-e,LIU Yi-shuang,DUAN Chun-yan.Correlation between TEG Parameters and PAgT and D-Dimer in Patients with ACIH[J].Journal of Modern Laboratory Medicine,2017,32(06):134.[doi:10.3969/j.issn.1671-7414.2017.01.037]
[2]王 禺,李秀娥,赵 曼,等.急性脑梗死患者的NT-proBNP和Hcy及部分凝血纤溶指标变化的临床意义[J].现代检验医学杂志,2017,32(03):89.[doi:10.3969/j.issn.1671-7414.2017.03.024]
　WANG Yu,LI Xiu-e,ZHAO Man,et al.Clinical Significance of Changes in NT-proBNP，Hcy and Partial Coagulation-Fibrinolytic Indexes with Acute Cerebral Infarction[J].Journal of Modern Laboratory Medicine,2017,32(06):89.[doi:10.3969/j.issn.1671-7414.2017.03.024]
[3]刘学芳,霍 豆,赵 茜,等.急性脑梗死患者血清VEGF,SAA和Lp-PLA2联合检测的临床研究[J].现代检验医学杂志,2018,33(04):76.[doi:10.3969/j.issn.1671-7414.2018.04.020]
　LIU Xue-fang,HUO-Dou,ZHAO-Qian,et al.Diagnostic Value of Combined Detection of VEGF,SAA and Lp-PLA2 for Acute Cerebral Infarction[J].Journal of Modern Laboratory Medicine,2018,33(06):76.[doi:10.3969/j.issn.1671-7414.2018.04.020]
[4]张同庆,杨文东.急性脑梗死并发幽门螺旋杆菌感染者血脂水平及氧化应激反应的观察[J].现代检验医学杂志,2018,33(02):66.[doi:10.3969/j.issn.1671-7414.2018.02.001]
　ZHANG Tong-qing,YANG Wen-dong.Observation of Serum Lipid Level and Oxidative Stress Response in Patients with Acute Cerebral Infarction Complicated with Helicobacter Pylori Infection[J].Journal of Modern Laboratory Medicine,2018,33(06):66.[doi:10.3969/j.issn.1671-7414.2018.02.001]
[5]刘 莉,张 军.急性脑梗死患者血清hs-CRP,TNF-α和TIMP-1水平检测在疾病预后评估中的应用价值[J].现代检验医学杂志,2018,33(05):87.[doi:10.3969/j.issn.1671-7414.2018.05.023]
　LIU Li,ZHANG Jun.Value of Serum hs-CRP,TNF-α and TIMP-1 Levels in Prognostic Evaluation of Patients with Acute Cerebral Infarction[J].Journal of Modern Laboratory Medicine,2018,33(06):87.[doi:10.3969/j.issn.1671-7414.2018.05.023]
[6]陈 霏,王 碧.血清PDGF 及SDF-1 水平与急性脑梗死患者脑侧支循环建立的相关性研究[J].现代检验医学杂志,2020,35(01):82.[doi:10.3969/j.issn.1671-7414.2020.01.022]
　CHEN Fei,WANG Bi.Study on the Correlation between Levels of MMP-9 and SDF-1 in Serumand the Establishment of Cerebral Collateral Circulation inPatients with Acute Cerebral Infarction[J].Journal of Modern Laboratory Medicine,2020,35(06):82.[doi:10.3969/j.issn.1671-7414.2020.01.022]
[7]王 淼,玄洪雷.老年急性脑梗死患者血清Pannexin1 和sTREM-1 表达水平及其与病情和预后的相关性研究[J].现代检验医学杂志,2022,37(04):123.[doi:10.3969/j.issn.1671-7414.2022.04.024]
　WANG Miao,XUAN Hong-lei.Serum Pannexin1 and sTREM-1 Expression Levels in Elderly Patients with Acute Cerebral Infarction and Their Correlation with Disease and Prognosis[J].Journal of Modern Laboratory Medicine,2022,37(06):123.[doi:10.3969/j.issn.1671-7414.2022.04.024]
[8]聂晓慧,薛 茜,寇文辉,等.急性脑梗死患者外周血LncRNA-NEAT1，miR-93-5p 表达水平及临床意义[J].现代检验医学杂志,2022,37(06):94.[doi:10.3969/j.issn.1671-7414.2022.06.017]
　NIE Xiao-hui,XUE Qian,KOU Wen-hui,et al.Expression Level and Clinical Significance of Peripheral Blood LncRNANEAT1 and miR-93-5p in Patients with Acute Cerebral Infarction[J].Journal of Modern Laboratory Medicine,2022,37(06):94.[doi:10.3969/j.issn.1671-7414.2022.06.017]
[9]张 磊,赵腾跃,李 彬.急性脑梗死患者血清Beclin-1，3-MST，TSP-1 表达水平及与病情和预后的相关性研究[J].现代检验医学杂志,2022,37(06):124.[doi:10.3969/j.issn.1671-7414.2022.06.023]
　ZHANG Lei,ZHAO Teng-yue,LI Bin.Serum Beclin-1, 3-MST and TSP-1 Expression Levels in Patients with Acute Cerebral Infarction and Their Correlation with Disease Condition and Prognosis[J].Journal of Modern Laboratory Medicine,2022,37(06):124.[doi:10.3969/j.issn.1671-7414.2022.06.023]
[10]牛立远a,刘会雪a,史立彬b.急性脑梗死患者血清CCR5 和miR-211-5p 表达水平及其临床意义[J].现代检验医学杂志,2023,38(01):128.[doi:10.3969/j.issn.1671-7414.2023.01.024]
　NIU Li-yuana,LIU Hui-xuea,SHI Li-binb.Expression Levels and Their Clinical Significance of Serum CCR5 and miR-211-5p in Patients with Acute Cerebral Infarction[J].Journal of Modern Laboratory Medicine,2023,38(06):128.[doi:10.3969/j.issn.1671-7414.2023.01.024]

备注/Memo

备注/Memo:
基金项目：邢台市重点研发计划项目(2020ZC210)。
作者简介：杨华(1980-)，女，本科，副主任检验师，主要研究方向：临床检验，E-mail：yangh173@126.com。
通讯作者：黄红革，女，主任检验师，E-mail：xthhg@126.com。
更新日期/Last Update: 2022-11-15